These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 16963733)

  • 1. Is there a role for SV40 in human cancer?
    Poulin DL; DeCaprio JA
    J Clin Oncol; 2006 Sep; 24(26):4356-65. PubMed ID: 16963733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association.
    Dang-Tan T; Mahmud SM; Puntoni R; Franco EL
    Oncogene; 2004 Aug; 23(38):6535-40. PubMed ID: 15322523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer.
    Engels EA; Chen J; Viscidi RP; Shah KV; Daniel RW; Chatterjee N; Klebanoff MA
    Am J Epidemiol; 2004 Aug; 160(4):306-16. PubMed ID: 15286015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simian virus 40, poliovirus vaccines, and human cancer: research progress versus media and public interests.
    Butel JS
    Bull World Health Organ; 2000; 78(2):195-8. PubMed ID: 10743284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.
    Cutrone R; Lednicky J; Dunn G; Rizzo P; Bocchetta M; Chumakov K; Minor P; Carbone M
    Cancer Res; 2005 Nov; 65(22):10273-9. PubMed ID: 16288015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines.
    Hirvonen A; Mattson K; Karjalainen A; Ollikainen T; Tammilehto L; Hovi T; Vainio H; Pass HI; Di Resta I; Carbone M; Linnainmaa K
    Mol Carcinog; 1999 Oct; 26(2):93-9. PubMed ID: 10506753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993.
    Olin P; Giesecke J
    Dev Biol Stand; 1998; 94():227-33. PubMed ID: 9776244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of SV40 with human tumours.
    Jasani B; Cristaudo A; Emri SA; Gazdar AF; Gibbs A; Krynska B; Miller C; Mutti L; Radu C; Tognon M; Procopio A
    Semin Cancer Biol; 2001 Feb; 11(1):49-61. PubMed ID: 11243899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does simian virus 40 cause non-Hodgkin lymphoma? A review of the laboratory and epidemiological evidence.
    Engels EA
    Cancer Invest; 2005; 23(6):529-36. PubMed ID: 16203661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
    Engels EA; Viscidi RP; Galloway DA; Carter JJ; Cerhan JR; Davis S; Cozen W; Severson RK; de Sanjose S; Colt JS; Hartge P
    J Natl Cancer Inst; 2004 Sep; 96(18):1368-74. PubMed ID: 15367569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of SV40 infection in patients with nodal non-Hodgkin's lymphoma but not acute leukemia independent of contaminated polio vaccines in Taiwan.
    Chen PM; Yen CC; Yang MH; Poh SB; Hsiao LT; Wang WS; Lin PC; Lee MY; Teng HW; Bai LY; Chu CJ; Chao SC; Yang AH; Chiou TJ; Liu JH; Chao TC
    Cancer Invest; 2006; 24(3):223-8. PubMed ID: 16809147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral polio vaccine and human cancer: a reassessment of SV40 as a contaminant based upon legal documents.
    Kops SP
    Anticancer Res; 2000; 20(6C):4745-9. PubMed ID: 11205211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA.
    Sierra-Honigmann A; Krause PR
    Biologicals; 2000 Mar; 28(1):1-4. PubMed ID: 10799049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk associated with simian virus 40 contaminated polio vaccine.
    Fisher SG; Weber L; Carbone M
    Anticancer Res; 1999; 19(3B):2173-80. PubMed ID: 10472327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of serologic evidence for prevalent simian virus 40 infection in humans.
    Carter JJ; Madeleine MM; Wipf GC; Garcea RL; Pipkin PA; Minor PD; Galloway DA
    J Natl Cancer Inst; 2003 Oct; 95(20):1522-30. PubMed ID: 14559874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research.
    Engels EA
    Expert Rev Vaccines; 2005 Apr; 4(2):197-206. PubMed ID: 15889993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to SV40-contaminated poliovirus vaccine and the risk of cancer--a review of the epidemiological evidence.
    Strickler HD; Goedert JJ
    Dev Biol Stand; 1998; 94():235-44. PubMed ID: 9776245
    [No Abstract]   [Full Text] [Related]  

  • 18. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates.
    Strickler HD; Rosenberg PS; Devesa SS; Hertel J; Fraumeni JF; Goedert JJ
    JAMA; 1998 Jan; 279(4):292-5. PubMed ID: 9450713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyomavirus SV40 infections in Kazakhstan.
    Nurgalieva ZZ; Wong C; Zhangabylov AK; Omarbekova ZE; Graham DY; Vilchez RA; Butel JS
    J Infect; 2005 Feb; 50(2):142-8. PubMed ID: 15667916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of SV40-like sequences in ependymal tumours.
    Reuther FJ; Löhler J; Herms J; Hugo HH; Schindler C; Leithäuser F; Melzner I; Möller P; Scheil S
    J Pathol; 2001 Dec; 195(5):580-5. PubMed ID: 11745694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.